MARKET RESEARCH ANALYTIC REPORTS FOR ALL INDUSTRY

Wednesday, 1 March 2017

Vascular Closure Devices Market Size and Forecast by Product, End-Use, and Trend Analysis from 2013 to 2024

Global Vascular Closure Devices (VCDS) Market is anticipated to reach USD 1.3 billion by 2024, according to a new report by Grand View Research, Inc. Growing popularity of femoral artery cardiac catheterization and high success rate of VCDs for improved patient comfort and shortening of haemostasis time are potential factors for the projected growth of VCDs market over the forecast period. Adoption of VCDs for diagnostic and therapeutic interventions that facilitate endovascular image-guided interventions to detect coronary heart disease are expected to contribute toward the growth of this market throughout the forecast period.

Moreover, ability of VCDs to overcome complications, such as prolonged bed rest and patient discomfort caused by manual compression, is expected to revolutionize the market growth over the forecast period.

Access For Full Detail of Report and Complete TOC: http://www.grandviewresearch.com/industry-analysis/vascular-closure-device-vcd-market

Further Key Findings from the Study Suggest:

VCDs offer three types of products, which includes active approximators, passive approximators, and external hemostatic devices. Out of all three, active approximators dominated the market in 2015 as they shorten the time to ambulation and possess high efficiency rate.
Amongst the different end-users of VCDs, acute care facilities accounted for the largest share and are expected to maintain their dominant position over the forecast period. This is attributed to the rising popularity of VCDs in acute care treatment facilities.
Asia Pacific is estimated to witness the fastest growth over the forecast period owing to the presence of unmet demands by the hospitals and rising R&D investment in this region.
Some key players operating in this industry include Cardinal Health; Abbott Laboratories; COOK; Medtronic; W L. Gore & Associates; Boston Scientific Corporation; Biotronik GMBH & CO.KG; TZ Medical, Inc.; C. R. Bard, Inc.; ST. JUDE MEDICAL; Cardiva Medical, Inc.; Merit Medical Systems, Inc.; ESSENTIAL MEDICAL, INC; and Scion BioMedical.
This market is expected to witness lucrative growth owing to high level of competitive rivalry, which translates to high revenue generation in this sector. These prominent players are opting for different strategies to boost their status in this market. Companies are involved in developing novel VCDs and in turn broaden their product portfolios. Acquisition and collaboration with small companies in order to enhance presence is also expected to propel growth in this vertical.
For instance, in October 2015, Cardinal Health acquired Johnson & Johnson's Cordis business. Cordis is a leader in manufacturing and marketing of cardiology and endovascular devices. This acquisition was intended to expand Cardinal’s VCD product catalog to reinforce its status in the market.
North America dominated the market in 2015, with over 33% of total revenue. The presence of key players in this region, which are primarily involved in marketing and development of innovative VCDs, to facilitate cardiac surgeries can be attributed to the largest share of North America. Demand of products for monitoring of coronary artery disease is also expected to drive growth.

View all Related Reports from same Category by Grand View Research: http://www.grandviewresearch.com/industry/biotechnology

Grand View Research has segmented vascular closure devices market on the basis of product, end use, and region:

Global Vascular Closure Devices Outlook, by Product (Revenue, USD Million, 2013 - 2024)

Active Approximators
- Suture-based Devices
- Clip-based Devices
Passive Approximators
Collagen Plugs
Sealant- or Gel-based Devices
Compression-Assist Devices
External Hemostatic Devices

Global Vascular Closure Devices Outlook, by End Use (Revenue, USD Million, 2013 - 2024)

Acute Care Facilities
Hospitals
Clinics

Global Vascular Closure Devices Regional Outlook (Revenue, USD Million, 2013 - 2024)

North America
- U.S.
- Canada
Europe
Germany
UK
China
Japan
Brazil
Mexico
Argentina
Chile
Colombia
Peru
Venezuela
Ecuador
Panama
Costa Rica
South Africa
Asia Pacific
Latin America
MEA

About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more Information visit us@ www.grandviewresearch.com

Vein Illuminator Market Outlook 2014-2024 by Market Drivers and Restraints, along with their Current and Expected Impacts

Global Vein Illuminator Market is expected to reach USD 358.5 million by 2024, according to a new report published by Grand View Research, Inc. The vein illuminator market is anticipated to witness a lucrative growth during the period 2016 to 2024. The factors contributing towards the growth of the market are the growing aging population and the efforts channelized towards improving patient satisfaction. Additionally, factors, such as the demand for technologically advanced medical equipment and the rising research and practical applications are expected to be opportunistic for the industry growth. However, the prevalence of traditional methods owing to the high costs of the vein illuminator devices is likely to hinder the growth of the market in the near future.

The vein illuminator market is segmented on the basis of technology, application, end-user, and region. Based on technology, the market is further categorized into transillumination, infrared technology, and ultrasound. The near-infrared illumination technology is estimated to be the largest shareholder due to its ability to penetrate deep into the tissue, which makes it possible to visualize the vessels clearly.

On the basis of application, the market is segmented into intravenous access and blood draw. The end-user segment comprises hospitals, rehabilitation facilities, blood donation camps, and academic institutions. The market for hospitals is expected to grow rapidly during the forecast period due to a surge in the demand for technologically advanced medical equipment. The market is also categorized into North America, Europe, Asia Pacific, MEA, and Latin America.

Access for full Detail of Report and Complete TOC: http://www.grandviewresearch.com/industry-analysis/vein-illuminator-market

Further key findings from the study suggest:

In terms of market share, the North America vein illuminator market is expected to hold majority of the share in 2016. Factors resulting in the growth of this industry are the steady preference for highly-advanced medical devices by hospitals as well as the presence of several medical device manufacturing companies in the region.
The infrared illumination technology is estimated to lead the industry due to its deep penetration capability into thick tissues to highlight the presence of vessels with increased clarity. Based on application, the segment for intravenous access is estimated to be the largest shareholder, followed by the blood draw segment.
The vein illuminator industry comprises several local as well as global players. Some prominent players in this industry include Accuvein, Inc., Christie Medical Holdings, Inc., Infrared Imaging Systems, Inc., Translite, LLC, and Venoscope, LLC,among others. In order to hold a major share in the industry, the companies are adopting both organic as well as inorganic strategies. The major strategies adopted by the companies are new product development, mergers, collaborations, partnerships, geographical expansions, and acquisitions.
The companies are also focusing on research and development activities in order to enhance their product portfolio. For instance, in September 2015, Accuvein, Inc., declared its 26^th patent, which was issued by the United States Patent and Trademark office for their vein visualization system.

View all Related Report from Same Category by Grand View Research: http://www.grandviewresearch.com/industry/medical-devices

Grand View Research has segmented the vein illuminator market on the basis of technology, application, and end-user application:

Vein Illuminator Technology Outlook (Revenue, USD Million, 2013 - 2024)

Trans illumination
Infrared technology
Others

Vein Illuminator Application Outlook (Revenue, USD Million, 2013 - 2024)

Intravenous access
Blood draw
Others

Vein Illuminator End-user Outlook (Revenue, USD Million, 2013 - 2024)

Hospitals
Blood donation camps
Academic institutions
Others

Vein Illuminator Regional Outlook (Revenue, USD Million, 2013 - 2024)

North America
Europe
Asia Pacific
Latin America
MEA

Baby Product Market Report Covers Revenue Forecast, Competitive Landscape, Growth Factors and Trends

Global Baby Product Market is expected to reach USD 121.0 billion by 2025, according to a new report by Grand View Research, Inc. Rising spending capability in matured economies of North America and Europe will augment industry growth over the next nine years.

Increasing birth rate in emerging economies of Asia Pacific including India and China is anticipated to drive the demand for infant items over the forecast period. Rising awareness among the customers about infant nutrition, hygiene, and safety in the region will fuel demand over the forecast period. Continuous innovation among manufactures is expected to propel industry growth over the forecast period.

Cosmetics & toiletries held the largest share in the market. Cosmetics help to enhance infant skin, provide nourishment, resist swelling, itching, rashes and inflammations. Apart from that it tends to posses’ antibacterial, antifungal, antimicrobial, which soothe and provide luster to the skin. These beneficial properties are expected to drive the demand over the forecast period.

Infant food provides essential ingredients which include vitaminB12, protein, carbohydrate, and iron which are required in different growth phases of babies, so as to develop a good immune system. Rising number of food varieties coupled with its ease of use when travelling is expected to have a positive impact on the market over the forecast period.

Access for full Detail of Report and Complete TOC: http://www.grandviewresearch.com/industry-analysis/baby-products-market

Further key findings from the report suggest:

Baby product market is expected to witness growth at a CAGR of 6.9% from 2016 to 2025 owing to increased female working population resulting in higher demand for ready-to-use items
Cosmetics & toiletries will witness the fastest growth at a CAGR of 7.3% from 2016 to 2024 owing to rising awareness regarding infant hygiene
Asia Pacific market was estimated at over USD 17 billion in 2015 on account of growing awareness about baby nutrition, hygiene and safety coupled with increased disposable income
Key participants include Procter & Gamble Company, Kimberly-Clark Corporation, Johnson & Johnson Plc, Unilever Plc, Nestle S. A, and Abbott Nutrition
Key companies in the market are focused on increasing their global presence through mergers & acquisitions and brand awareness. In November 2016, Dabur South Africa (Pty) Ltd acquired South Africa’s CTL Group of Companies personal care, hair care & creams businesses for USD 1.3 million
In July 2016, Johnson & Johnson Consumer Inc. completed the acquisition of Vogue International LLC, which is engaged in the manufacturing and distribution of hair care and other personal care products for $3.3 billion

View Related Reports From Same Category by Grand View Research: http://www.grandviewresearch.com/industry/personal-care-and-cosmetics

Grand View Research has segmented the global baby product market on the basis of product and region:

Baby Product Outlook (Revenue, USD Billion, 2014 - 2025)

Cosmetic & Toiletries
- Baby Skin Care Products
- Bath Products
- Baby Hair Care Products
- Other Cosmetics & Toiletries
Baby Food
Milk Products
Frozen Baby Food
Baby Juice
Baby Food Snacks
Baby Food Cereals
Baby Strollers
Baby Car Seats
Baby Safety & Convenience

Baby Product Market Regional Outlook (Revenue, USD Billion, 2014 - 2025)

North America
- U.S.
Europe
UK
Germany
China
India
Japan
Brazil
Asia Pacific
South & Central America
Middle East & Africa (MEA)

Small Arms Light Weapons Market Segmentation on the basis of Type, Application, And Region

Global Small Arms Light Weapons Market is expected to reach USD 25.76 billion by 2024, according to a new report by Grand View Research, Inc. The increasing issues on human rights and safety and security are expected to drive the demand. The increasing effects of urban warfare along with increasing terrorism incidents have also led to the development of the small arms light weapons across various regions. An increase in the urban warfare along with increased terrorist activity is anticipated to propel the market growth. The development of light-weight weapons for further enhancement of defence system is an ongoing trend in the developed countries.

Increasing criminal activities and human rights violations have resulted in the increased efforts for the technology advancements and modernization of the weapons utilized by law enforcement. The Combat Development and Integration Command’s Fires and Manoeuvre Integration Division of marines introduced the small arms modernization strategy which is expected to focus on updating and developing the current weapons in short-term and futuristic systems that could hit the fleet in the 2020s.

The governments of various countries are also investing their resources for the development of highly sophisticated weapon accessories such as night vision devices, laser rangefinders, weapon sights, aiming lasers, and fire control systems. High investment in the defence Research & Development (R&D) for shoulder –wired weapons made for developing a highly robust, reliable, and durable weapons system has also catapulted the demand for light weapons in military applications. The limited defence budget to boost the development of defence system is expected to hinder the market growth.

Access for full Detail of Report and Complete TOC: http://www.grandviewresearch.com/industry-analysis/small-arms-light-weapons-salw-market

Further key findings from the study suggest:

In 2015, light weapons market accounted for over 60% of the overall market share and is also expected to significantly growth over the forecast period. The implementation of modernization programs for police and the military forces is expected to drive the growth.
Rifles in small arms segment are expected to witness a significant growth at a CAGR of over 20% over the forecast period. The increasing interest of civilians in the shooting sports is expected to be the reason for growth.
Grenade and grenade launchers are expected to witness enormous growth in the light weapons segment owing to increased stress between countries and increased development of grenade launchers
The military application segment is anticipated to witness substantial growth and is estimated to reach over USD 13.0 billion by 2024. The widespread geographic presence of terrorism and human rights violation had led to the increased demand of light weapons market. Increased violation of civilians rights and law enforcement regulations have also triggered its growth.
The Asia Pacific SALW market is anticipated to grow at a CAGR of over 25% over the forecast period. Increasing technology and economic developments in the emerging countries such as China and India with their cross-border disputes has contributed to the growth.
Notable companies operating in the SALW market include Raytheon, Berette S.p.A., GLOCK Ges m.b.H., and FN Herstal SA

View all Related Reports from Same Category: http://www.grandviewresearch.com/industry/emerging-and-next-generation-technologies

Grand View Research has segmented the global SALW market on the basis of type, application, and region:

SALW Type Outlook (Revenue, USD Million; 2014 - 2024)

Small Arms
Light Weight

SALW Application Outlook (Revenue, USD Million; 2014 - 2024)

Military
Law Enforcement

SALW Regional Outlook (Revenue, USD Million; 2014 - 2024)

North America
- U.S.
- Canada
- Mexico
Europe
UK
Germany
France
Russia
China
Japan
India
South Korea
MEA
South America
Asia Pacific
RoW

Tuesday, 28 February 2017

Transplant Diagnostic Market Forecasting Include Regulatory Scenario and Expected Developments 2024

Global Transplant Diagnostic Market is expected to reach USD 895.2 million by 2024, according to a new report by Grand View Research Inc. The rising demand for organ transplantation is primarily fuelling the demand for transplant diagnostics.

Constant healthcare research and development efforts are resulting in the introduction of technically advanced treatments, such as stem cell therapy and organ transplants. As a result, the adoption of these highly-advanced organ transplantation techniques is creating the demand for transplant diagnostics as they reduce the risk of infections and minimize the chances of an immune response through pre-operative assessments including histocompatibility tests, such as Human Leukocyte Antigen (HLA) typing, which determines donor-receiver organ or tissue compatibility prior to organ transplants.

In addition, pertinent organizations are supporting research and development initiatives in the field of organ transplant through grants and funding. As a result, innovative and advanced diagnostic tools are frequently entering into the market. On the other hand, high cost of the diagnostic tests is one of the major factors hindering the growth of the market.

Geographically, the market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East and Africa (MEA). North America and Europe together accounted for the largest market share in 2015. Developed economies and well-established healthcare infrastructure coupled with the presence of a highly developed research infrastructure are accelerating the adoption of organ and tissue transplant therapies in Europe and North America. As a consequence, the demand for transplant diagnostics is high in North America and Europe.

Wide adoption of HLA typing owing to its ability to determine organ compatibility between the donor and the receiver preceding organ transplants and to predict potential perioperative immunological complications is driving the growth of the molecular assay market in North America and Europe.

Asia Pacific is expected to show the fastest growth rate during the forecast period owing to the booming medical tourism in countries, such as India. Availability of advanced healthcare infrastructure and skilled professionals at a lower cost are anticipated to attract patients worldwide to this region for transplant procedures.

In addition, the presence of highly advanced healthcare infrastructure and the ongoing government initiatives to improve healthcare facilities in the country are collectively anticipated to boost the market growth in Japan during the forecast period. As a result, the Asia Pacific market is anticipated to reach USD 216.6 million in 2024.

Access for full Detail of Report and Complete TOC: http://www.grandviewresearch.com/industry-analysis/transplant-diagnostic-market

Further key findings from the study suggest:

The PCR-based molecular assay captured the largest share of the overall market in 2015. The large market share was mainly attributed to the extensive adoption of the PCR technique in HLA typing.
The sequencing-based typing segment is anticipated to witness significant growth rate from 2016 to 2024. The escalation in the adoption of next generation sequencing (NGS) is the major factor expected to drive the growth of this segment during the forecast period.
The integration of sequencing with serological typing enhances diagnostic outcomes and, hence is expected to augment the growth of the sequencing segment during the forecast period
The reagents and consumables segment accounted for the largest market share in 2015. This large share is mainly attributed to the repeat purchase of these products.
North America captured the largest market share of around 38% in 2015 and is expected to maintain its dominance throughout the forecast period. Well-established research infrastructure, the increasing healthcare expenditure, high adoption rate of the advanced diagnostic techniques, and the growing R&D activities are some of the factors supporting the growth of the market in the region.
Asia Pacific is expected to witness significant growth during the forecast period owing to the expanding research opportunities, the increasing health care expenditure, and the rising awareness of organ donation in the region.
The booming medical tourism industry offers further growth opportunities for the market in Asia Pacific
Some major players in this market include Thermo Fisher Scientific, Inc., Illumina, Inc., F.Hoffmann La-Roche AG. Abbott Laboratories, Inc., Qiagen N.V., Immucor Transplant Diagnostics, Inc., Bio-Rad Laboratories, Inc., Affymetrix, Inc., and Omixon Ltd.

Browse Related Reports from same Category: http://www.grandviewresearch.com/industry/healthcare

Grand View Research has segmented the Transplant Diagnostic Market on the basis of technology, product, and geography.

Transplant Diagnostic Market by Technology, 2013 - 2024 (USD Million)

Molecular Assays
- PCR-Based Molecular Assays
- Sequencing-Based Molecular Assays
Non-Molecular Assays
Serological Assays
Mixed Lymphocyte Culture (MLC) Assays

Transplant Diagnostic Market by Product, 2013 - 2024 (USD Million)

Reagents and Consumables
Instruments
Software and Services

Transplant Diagnostics Market, by Region, 2013- 2024 (USD Million)

North America
- U.S. Transplant Diagnostics Market by Product Type
- Canada Transplant Diagnostics Market by Product Type
- U.S.Transplant Diagnostics Market by Technology Type
- Canada Transplant Diagnostics Market by Technology
Europe
Germany Transplant Diagnostics Market by Product Type
France Transplant Diagnostics Market by Product Type
Germany Transplant Diagnostics Market by Technology
France Transplant Diagnostics Market by Technology
China Transplant Diagnostics Market by Product Type
India Transplant Diagnostics Market by Product Type
China Transplant Diagnostics Market by Technology
India Transplant Diagnostics Market by Technology
Brazil Transplant Diagnostics Market by Product Type
Mexico Transplant Diagnostics Market by Product Type
Brazil Transplant Diagnostics Market by Technology
Mexico Transplant Diagnostics Marketby Technology
South Africa Transplant Diagnostics Market by Product Type
South Africa Transplant Diagnostics Market by Technology
Asia Pacific
Latin America
MEA

Tumor Ablation Market Forecasting Include Disease Prevalence and Incidence Trends and Demographic Trends 2022

Global tumor ablation market is expected to reach USD 1.5 billion by 2022, according to a new study by Grand View Research Inc. Rising prevalence of different forms of cancer and increasing technological advancements in the field of thermal ablation techniques are the most prominent drivers of the market.

Besides the use of thermal ablation, techniques such as laser ablation, irreversible electroporation, High Intensity Focused Ultrasonography (HIFU) are also clinically growing, concurrently propelling the tumor ablation industry.
Occurrence of lung, breast, and liver cancer is on the rise globally. According to the Center for Disease Control (CDC) and other organizations, currently, about 210,828 cases of lung cancer, 2.9 million cases of breast cancer, and over 2.7 million cases of prostate cancer are reported in the U.S. alone.

In terms of technological advancement, companies such as SonaCare Medical are coupling ablation techniques with other technologies to improve accuracy, performance, and level of care. SonaLink, a remote patient monitoring platform, was put to use along with Sonatherm ablation system to enable physicians to enhance patient care experience, thereby promoting market growth.
The industry is also anticipated to witness mergers and joint collaborations as a tool to curb rising competition. For instance, Boston Scientific Corporation acquired C.R. Bard Electrophysiology, which led to a 48.0% hike in profit for the former company.

Access for full Detail of Report and Complete TOC: http://www.grandviewresearch.com/industry-analysis/tumor-ablation-market

Further key findings from the study suggest:

Microwave ablation technology is expected to be the fastest growing segment over the forecast period at a CAGR of over 15.0%. Reduction in the procedure time and low cost for treatment are some of the attributes favoring growth.
In terms of treatment, surgical ablation is predicted to form the largest market by 2022 with about 35.0% share. Liver and lung cancer ablation require surgical procedures, and since these form the largest and fastest growing segments, they concomitantly propel surgical ablation growth.
Lung cancer forms the most lucrative market and is anticipated to be the fastest growing segment over the forecast period. By 2022, it is expected to contribute about 15.0% of the revenue share owing to its rising prevalence rate across the globe.
According to market forecast for 2022, North America is expected to dominate the market and Asia Pacific is anticipated to witness the fastest growth. Augmenting growth in the cancer prevalence and rising healthcare expenditure in regions such as China, Korea, and India are factors responsible for this rapid growth.
Major players of the market include HealthTronics, Galil Medical Inc., Angiodynamics, Medtronic Plc. (Covidien), Boston Scientific Corporation, SonaCare Medical, Misonix Inc., EDAP TMS S.A., and Neuwave Medical Inc. To retain market leadership, players such as Medtronic are working towards acquiring other companies and expanding their portfolio. For instance, in January 2016, Medtronic acquired the OsteoCool RF Ablation System from Baylis Medical.

Browse Related Reports from same Category: http://www.grandviewresearch.com/industry/medical-devices

Grand View Research has segmented the global tumor ablation market on the basis of technology, treatment, application, and region

Global Tumor Ablation Technology Outlook (USD million), 2012 - 2022

Radiofrequency
Microwave ablation
Cryoablation
Other ablation technologies

Global Tumor Ablation Treatment Outlook (USD million), 2012 - 2022

Surgical tumor ablation
Laparoscopic tumor ablation
Percutaneous tumor ablation

Global Tumor Ablation Application Outlook (USD million), 2012 - 2022

Liver cancer
Breast cancer
Lung cancer
Prostate cancer
Other cancers

Tumor Ablation Region Outlook (USD million), 2012 - 2022
·         North America
·         U.S.
§  U.S. tumor ablation market technology outlook
·         Radiofrequency
·         Microwave ablation
·         Cryoablation
·         Other ablation technologies
§  U.S. tumor ablation market treatment outlook
·         Surgical tumor ablation
·         Laparoscopic tumor ablation
·         Percutaneous
§  U.S. tumor ablation market application outlook
·         Liver cancer
·         Breast cancer
·         Lung cancer
·         Prostate cancer
·         Other cancer
·         Canada
§  Canada tumor ablation market technology outlook
·         Radiofrequency
·         Microwave ablation
·         Cryoablation
·         Other ablation technologies
§  Canada tumor ablation market treatment outlook
·         Surgical tumor ablation
·         Laparoscopic tumor ablation
·         Percutaneous
§  Canada tumor ablation market application outlook
·         Liver cancer
·         Breast cancer
·         Lung cancer
·      Prostate cancer
·         Other cancer
·         Europe
·         UK
§  UK tumor ablation market technology outlookUK tumor ablation market treatment outlook
·         Radiofrequency
·         Microwave ablation
·         Cryoablation
·         Other ablation technologies
·         Surgical tumor ablation
·         Laparoscopic tumor ablation
·         Percutaneous
§  UK tumor ablation market application outlook
·         Liver cancer
·         Breast cancer
·         Lung cancer
·         Prostate cancer
·         Other cancer
·         Germany
§  Germany tumor ablation market technology outlook
·         Radiofrequency
·         Microwave ablation
·         Cryoablation
·         Other ablation technologies
§  Germany tumor ablation market treatment outlook
·         Surgical tumor ablation
·         Laparoscopic tumor ablation
·         Percutaneous
§  Germany tumor ablation market application outlook
·         Liver cancer
·         Breast cancer
·         Lung cancer
·         Prostate cancer
·         Other cancer
·         Asia Pacific
·         Japan
§  Japan tumor ablation market technology outlook Japan tumor ablation market treatment outlook
·         Radiofrequency
·         Microwave ablation
·         Cryoablation
·         Other ablation technologies
·         Surgical tumor ablation
·         Laparoscopic tumor ablation
·         Percutaneous
§  Japan tumor ablation market application outlook
·         Liver cancer
·         Breast cancer
·         Lung cancer
·         Prostate cancer
·         Other cancer
·         China
§  China tumor ablation market technology outlook
·         Radiofrequency
·         Microwave ablation
·         Cryoablation
·         Other ablation technologies
§  China tumor ablation market treatment outlook
·         Surgical tumor ablation
·         Laparoscopic tumor ablation
·         Percutaneous
§  China tumor ablation market application outlook
·         Liver cancer
·         Breast cancer
·         Lung cancer
·         Prostate cancer
·         Other cancer
·         Latin America
·         Brazil
§  Brazil tumor ablation market technology outlook
·         Radiofrequency
·         Microwave ablation
·         Cryoablation
·         Other ablation technologies
§  Brazil tumor ablation market treatment outlook
·         Surgical tumor ablation
·         Laparoscopic tumor ablation
·         Percutaneous
§  Brazil tumor ablation market application outlook
·         Liver cancer
·         Breast cancer
·         Lung cancer
·         Prostate cancer
·         Other cancer
·         Mexico
§  Mexico tumor ablation market technology outlook
·         Radiofrequency
·         Microwave ablation
·         Cryoablation
·         Other ablation technologies
§  Mexico tumor ablation market treatment outlook
·         Surgical tumor ablation
·         Laparoscopic tumor ablation
·         Percutaneous
§  Mexico tumor ablation market application outlook
·         Liver cancer
·         Breast cancer
·         Lung cancer
·         Prostate cancer
·         Other cancer
·         MEA
·         South Africa
§  South Africa tumor ablation market technology outlook
·         Radiofrequency
·         Microwave ablation
·         Cryoablation
·         Other ablation technologies
§  South Africa tumor ablation market treatment outlook
·         Surgical tumor ablation
·         Laparoscopic tumor ablation
·         Percutaneous
§  South Africa tumor ablation market application outlook
·         Liver cancer
·         Breast cancer
·         Lung cancer
·         Prostate cancer
·         Other cancer
·         Saudi Arabia
§  Saudi Arabia tumor ablation market technology outlook
·         Radiofrequency
·         Microwave ablation
·         Cryoablation
·         Other ablation technologies
§  Saudi Arabia tumor ablation market treatment outlook
·         Surgical tumor ablation
·         Laparoscopic tumor ablation
·         Percutaneous
§  Saudi Arabia tumor ablation market application outlook
·         Liver cancer
·         Breast cancer
·         Lung cancer
·         Prostate cancer
·         Other cancer

About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more Information visit us@ www.grandviewresearch.com